Letchworth, United Kingdom

Kevin E Parkes

This inventor holds 6 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1995-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kevin E Parkes: Innovator in Novel Alcohols

Introduction

Kevin E Parkes is a distinguished inventor based in Letchworth, GB. He has made significant contributions to the field of chemistry, particularly in the development of novel alcohols. With a total of 6 patents to his name, Parkes has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Parkes has focused on the creation of novel alcohols characterized by specific chemical formulas. These alcohols, where R.sup.a is azido or phthalimido, and R.sup.4 is a variety of groups including alkyl and aryl, are designed to serve as intermediates in the manufacture of amino acid derivatives with antiviral activity. The detailed processes for their manufacture highlight the innovative nature of his work.

Career Highlights

Kevin E Parkes is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to explore and develop his innovative ideas further, contributing to advancements in medicinal chemistry.

Collaborations

Throughout his career, Parkes has collaborated with notable colleagues, including Sally Redshaw and Gareth J Thomas. These partnerships have fostered a collaborative environment that enhances the creative process and leads to groundbreaking discoveries.

Conclusion

Kevin E Parkes is a prominent inventor whose work in novel alcohols has significant implications for the pharmaceutical industry. His contributions continue to pave the way for advancements in antiviral treatments and other applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…